2019
3039 Esophageal Ulcers: A Presenting Symptom of Acute HIV Infection
George R, Ketwaroo G, Verstovsek G. 3039 Esophageal Ulcers: A Presenting Symptom of Acute HIV Infection. The American Journal Of Gastroenterology 2019, 114: s1640-s1641. DOI: 10.14309/01.ajg.0000601688.27512.8b.Peer-Reviewed Original ResearchAcute HIV infectionHIV infectionEsophageal ulcerEsophageal ulcerationUnknown etiologyHIV-1Chronic human immunodeficiency virus (HIV) infectionSubsequent HIV viral loadAcute HIV-1 infectionHuman immunodeficiency virus (HIV) infectionLow absolute neutrophil countAbsolute neutrophil countDirect viral infectionHIV viral loadImmunodeficiency virus infectionSymptomatic HIV infectionAnti-retroviral therapyHIV-1 infectionAntibody differentiationEpigastric painGastroenterology providersMild leukopeniaRepeat EGDAcute esophagitisIndex endoscopy
2008
Dose Escalation of Gemcitabine Is Possible With Concurrent Chest Three-Dimensional Rather Than Two-Dimensional Radiotherapy: A Phase I Trial in Patients With Stage III Non–Small-Cell Lung Cancer
Zinner RG, Komaki R, Cox JD, Glisson BS, Pisters KM, Herbst RS, Kies M, Liao Z, Hong WK, Fossella FV. Dose Escalation of Gemcitabine Is Possible With Concurrent Chest Three-Dimensional Rather Than Two-Dimensional Radiotherapy: A Phase I Trial in Patients With Stage III Non–Small-Cell Lung Cancer. International Journal Of Radiation Oncology • Biology • Physics 2008, 73: 119-127. PMID: 18556142, DOI: 10.1016/j.ijrobp.2008.03.069.Peer-Reviewed Original ResearchMeSH KeywordsAbdomenAdultAgedAged, 80 and overAntimetabolites, AntineoplasticCarcinoma, Non-Small-Cell LungCombined Modality TherapyDeoxycytidineDose-Response Relationship, DrugDose-Response Relationship, RadiationFeasibility StudiesFemaleGemcitabineHumansLung NeoplasmsMaleMiddle AgedRadiation-Sensitizing AgentsRadiotherapy, ConformalTreatment OutcomeConceptsGrade 3 esophagitisDose of gemcitabineCell lung cancerTwo-dimensional radiotherapyLung cancerThree-dimensional conformal radiotherapySevere acute esophagitisWeekly gemcitabine concurrentCycles of gemcitabinePhase II doseStage III NSCLCDose-limiting toxicityPhase I trialThree-dimensional CRTChest radiotherapyConcurrent chestConcurrent radiotherapySevere esophagitisAcute esophagitisI trialDose escalationConformal radiotherapyEsophagitisApparent diseaseStage III
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply